Business · 19/02/1998Updated: 10/17/2026 · 1 min read
FDA Redesignates Animal Drug Regulations for Cephapirin Sodium Product
Summary
The FDA is updating its animal drug regulations to correctly categorize a product, Cephapirin Sodium for Intramammary Infusion, from other dosage forms to its intended intramammary form, following a redesignation process.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →